人乳低聚醣（HMO）市場規模、佔有率及成長分析（按類型、產品類型、應用、通路和地區分類）－2026-2033年產業預測

預計到 2024 年，人類乳寡糖 (HMO) 市場規模將達到 2.2964 億美元，到 2025 年將達到 2.533 億美元，到 2033 年將達到 5.5493 億美元，在預測期（2026-2033 年將達到 5.5493 億美元，在預測期（2026-2033 年）複合年成長率為 10.3%。

母乳低聚醣 (HMO) 作為嬰幼兒健康和營養的關鍵成分，市場正蓬勃發展。這些天然存在於母乳中的複雜碳水化合物具有顯著的健康益處，包括促進嬰幼兒免疫系統發育、消化功能和認知能力。人們對 HMO 益處的認知不斷提高，推動了市場需求，尤其是在旨在模擬母乳的嬰兒奶粉奶粉方面。這一成長與消費者尋求天然和整體健康解決方案的更廣泛趨勢不謀而合。此外，HMO 的潛在應用不僅限於嬰幼兒營養，還包括藥品、機能性食品和益生元等領域。然而，HMO 生產的複雜性和高成本，以及監管和智慧財產權方面的挑戰，都是必須克服的障礙，才能充分發揮市場的潛力。

人乳低聚醣（HMO）市場促進因素

人們對母乳寡糖 (HMO) 健康益處的認知不斷提高，是推動市場成長的關鍵因素。隨著消費者對 HMO 在增強嬰兒免疫功能、促進認知發展和改善腸道健康方面的重要作用了解得越來越深入，對 HMO 強化產品的需求持續成長。此外，HMO 對成人的潛在益處也進一步刺激了消費者的興趣和消費。這種日益成長的認知促使生產商不斷創新，將 HMO 添加到各種產品中，最終滿足了注重健康的消費者的需求，並擴大了整個 HMO 市場。

限制人乳低聚醣（HMO）市場的因素

由於人乳低聚醣 (HMO) 合成過程複雜且難度高，HMO 市場面臨嚴峻的挑戰。這些製程的複雜性不僅增加了實施難度，也阻礙了 HMO 生產的擴充性和成本效益。複製人乳中存在的各種 HMO 結構需要大量的資源和專業知識，導致生產成本居高不下。這些因素限制了市場成長和普及，使得製造商難以在滿足市場需求的同時，維持價格合理和生產效率高。

人乳低聚醣（HMO）市場趨勢

隨著人們探索嬰兒營養以外的應用，人類乳寡糖 (HMO) 市場正經歷重大變革。雖然傳統上 HMO 與母乳餵養密切相關，但目前越來越多的人開始將其應用於機能性食品、膳食補充劑和治療產品中，以應對各個年齡層面臨的各種健康挑戰。這種應用範圍的擴大凸顯了 HMO 的多方面效用，包括改善腸道健康、增強免疫反應以及潛在地緩解慢性疾病。隨著人們對 HMO 益處的認知不斷加深，預計 HMO 在主流保健產品中的應用將加速，從而創造新的機遇，並推動機能性食品和膳食補充劑領域的市場成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球人乳低聚醣（HMO）市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 2'FL
• 3'FL
• 3'SL
• 6'SL

全球人乳低聚醣（HMO）市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 岩藻糖基乳糖
• Lnt 和 LNnt
• 唾液酸乳糖

全球人乳低聚醣（HMO）市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 嬰兒奶粉
• 功能性食品和飲料
• 營養補充品
• 人類和動物保健成分
• 其他

全球人乳低聚醣（HMO）市場規模（依分銷通路分類）及複合年成長率（2026-2033 年）

• 大賣場和超級市場
• 藥局或藥房
• 量販店
• 百貨公司
• 單品牌商店
• 專賣店
• 線上銷售管道

全球人乳低聚醣（HMO）市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• DSM（Netherlands）
• BASF SE（Germany）
• DuPont（US）
• Nestle（Switzerland）
• Inbiose NV（Belgium）
• Gnubiotics Sciences SA（Switzerland）
• Abbott Laboratories（US）
• Royal FrieslandCampina NV（Netherlands）
• Elicityl SA（France）
• Dextra Laboratories（UK）
• Glycom A/S（Denmark）
• Glycosyn（US）
• Medolac Laboratories（US）
• Neolacta Lifesciences Pvt. Ltd.（India）
• Jennewein Biotechnologie GmbH（Germany）
• Lonza Specialty Ingredients（Switzerland）
• Kirin Holdings Company（Kyowa Hakko Bio）（Japan）
• ZuChem Inc.（US）

結論與建議

Human Milk Oligosaccharides (HMO) Market size was valued at USD 229.64 Million in 2024 and is poised to grow from USD 253.3 Million in 2025 to USD 554.93 Million by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The Human Milk Oligosaccharides (HMO) market is gaining traction as a crucial aspect of infant wellness and nutrition. These naturally occurring complex carbohydrates found in breast milk offer significant health benefits, promoting the development of the infant's immune system, gastrointestinal function, and cognitive skills. Increased awareness of their advantages fuels demand, particularly for infant formulas that aim to mimic breast milk. This growth aligns with a broader consumer trend toward seeking natural and holistic health solutions. Additionally, potential applications for HMOs extend beyond infant nutrition into pharmaceuticals, functional foods, and prebiotics. However, the complexity and high costs associated with HMO production, coupled with regulatory and intellectual property challenges, present hurdles that must be navigated to fully realize market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Human Milk Oligosaccharides (HMO) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Human Milk Oligosaccharides (HMO) Market Segments Analysis

Global Human Milk Oligosaccharides (HMO) Market is segmented by Type, Product, Application, Distribution channel and region. Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL and 6'SL. Based on Product, the market is segmented into Fucosyllactose, Lnt & LNnt and Sialyllactose. Based on Application, the market is segmented into Infant formula, Functional food & beverages, Food supplements, Health ingredients for human and animal and Other. Based on Distribution channel, the market is segmented into Hypermarkets and supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental stores, Mono-brand stores, Specialty stores and Online sales channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Human Milk Oligosaccharides (HMO) Market

The increasing recognition of the health benefits associated with human milk oligosaccharides (HMOs) is a significant catalyst for market growth. As consumers become more informed about the essential role HMOs play in enhancing immune function, supporting cognitive development, and improving gut health in infants, the demand for HMO-fortified products continues to rise. Additionally, the potential advantages of HMOs for adults are further boosting interest and consumption. This growing awareness is driving manufacturers to innovate and incorporate HMOs into a variety of products, ultimately catering to the health-conscious market and expanding the overall HMO market landscape.

Restraints in the Human Milk Oligosaccharides (HMO) Market

The Human Milk Oligosaccharides (HMO) market faces significant challenges due to the intricate and challenging processes involved in HMO synthesis. The complexity of these procedures not only makes them difficult to execute but also hampers the scalability and cost-effectiveness of HMO manufacturing. Replicating the diverse array of HMO structures found in breast milk requires substantial resources and expertise, which can result in higher production costs. These factors can limit market growth and accessibility, making it difficult for manufacturers to meet demand while maintaining affordability and efficiency in their production processes.

Market Trends of the Human Milk Oligosaccharides (HMO) Market

The Human Milk Oligosaccharides (HMO) market is witnessing a significant shift as research explores their applications beyond infant nutrition. While traditionally associated with breastfeeding, there is a growing trend to utilize HMOs in functional foods, dietary supplements, and therapeutics aimed at addressing various health concerns across diverse age groups. This expanded focus highlights the versatility of HMOs in enhancing gut health, boosting immune response, and potentially mitigating chronic diseases. As the understanding of HMO benefits evolves, their incorporation into mainstream health products is likely to accelerate, creating new opportunities and driving market growth in the functional food and health supplement sectors.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Human Milk Oligosaccharides (HMO) Market Size by Type & CAGR (2026-2033)

• Market Overview
• 2'FL
• 3'FL
• 3'SL
• 6'SL

Global Human Milk Oligosaccharides (HMO) Market Size by Product & CAGR (2026-2033)

• Market Overview
• Fucosyllactose
• Lnt & LNnt
• Sialyllactose

Global Human Milk Oligosaccharides (HMO) Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infant formula
• Functional food & beverages
• Food supplements
• Health ingredients for human and animal
• Other

Global Human Milk Oligosaccharides (HMO) Market Size by Distribution channel & CAGR (2026-2033)

• Market Overview
• Hypermarkets and supermarkets
• Drug store or pharmacy
• Mass merchandiser
• Departmental stores
• Mono-brand stores
• Specialty stores
• Online sales channel

Global Human Milk Oligosaccharides (HMO) Market Size & CAGR (2026-2033)

• North America (Type, Product, Application, Distribution channel)
  • US
  • Canada
• Europe (Type, Product, Application, Distribution channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Application, Distribution channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Application, Distribution channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Application, Distribution channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inbiose NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gnubiotics Sciences S.A (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal FrieslandCampina N.V (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elicityl S.A (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dextra Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycom A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycosyn (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medolac Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neolacta Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jennewein Biotechnologie GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Specialty Ingredients (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirin Holdings Company (Kyowa Hakko Bio) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZuChem Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations